Independence Blue Cross reports more members using generics compared with the national average for Blue Cross Blue Shield membership
Wednesday, 14 November 2018
Spending increases for brand drugs at Independence are lower than national averageAt more than $100 billion, prescription drugs represent more than 20 percent of overall health care spending for Blue Cross and Blue Shield (BCBS) commercially insured members. Prescription drug spending among branded specialty and patent-protected drugs continues to outpace generic drugs by $79.5 billion,...
Friday, 02 November 2018
Independence Chief Medical Officer Dr. Richard Snyder participates in state press conference about opioid prescription processes
Monday, 15 October 2018
Wednesday, 12 September 2018
Philadelphia, PA — Independence Blue Cross (Independence) is taking extra measures to help its members in areas affected by Hurricane Florence. For members impacted by Hurricane Florence in Maryland, North Carolina, South Carolina, Virginia, and Washington D.C., Independence will alter some of its policies now through October 12, 2018. Specific steps include: Waiving precertification, referral, and hospital admission requirements for medically necessary care for fully insured members....
Monday, 10 September 2018
In recognition of National Prostate Cancer Awareness Month, Independence Blue Cross (Independence) announces its continued support for the Prostate Cancer Foundation (PCF) in its ongoing efforts to promote awareness of prostate cancer throughout the Philadelphia region and nationwide. In addition to promoting a comprehensive guide about prostate cancer, Independence will make a financial contribution. According to the American Cancer Society (ACS),...
Independence Blue Cross to place additional restrictions on OxyContin® and Oxycodone ER to help reduce opioid use and abuse
Tuesday, 07 August 2018
Independence Blue Cross (Independence) announced that as part of its commitment to helping reduce opioid misuse and overprescribing, it is placing new restrictions on OxyContin® and Oxycodone ER. These products will be removed from some formularies and will require a new prior authorization on others, effective October 1. In addition, Xtampza® XR,...
Thursday, 02 August 2018
Thursday, 12 July 2018
Efforts have led to reduced opioid use, prescriptions, and abuseIn conjunction with a national Health of America report by the Blue Cross Blue Shield Association (BCBSA) about opioid use, Independence Blue Cross (Independence) is reporting the success it has achieved in addressing one of nation’s top health crises. The highlights of these results include: Reducing opioid use and prescriptions: Since 2014,...
Tuesday, 26 June 2018
Thursday, 10 May 2018